Clinical Trial Update: A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the combination of LY4395089 and mirikizumab, and mirikizumab alone, in adults with Crohn's disease; the study is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• LY4395089 (LY4395089)
• Mirikizumab (mirikizumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Crohn Disease | Phase 2 | Status: NOT_YET_RECRUITING